3.4. Triple Combination Therapy Controls Orthotopic Tumour Growth and Attenuates Metastasis in Pancreatic Cancer Within an Immunocompetent Model When Extending IL-2 Supplementation. Here, IL2 is linked to familial pancreatic carcinoma.